# Nutex Health Inc.: Form 10-K/A for the period ended Dec 31, 2018

- Company: [Nutex Health Inc.](/companies/nutx.md) (CIK 1479681)
- Form: 10-K/A
- Filed: 2019-04-17
- Accepted by EDGAR: Apr 17, 2019, 14:09 ET
- Period: 2018-12-31
- Accession: 0001607062-19-000163
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1479681/000160706219000163/igmb123118form10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479681/000160706219000163/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2018-01-01 to 2018-12-31 | $60.2k | us-gaap:Revenues |
| Cost of revenue | 12 months, 2018-01-01 to 2018-12-31 | $31.1k | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2018-01-01 to 2018-12-31 | $29.1k | us-gaap:GrossProfit |
| Operating income | 12 months, 2018-01-01 to 2018-12-31 | −$1.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2018-01-01 to 2018-12-31 | $642.1k | us-gaap:InterestExpense |
| Net income | 12 months, 2018-01-01 to 2018-12-31 | −$2.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2018-01-01 to 2018-12-31 | −$0.02 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months, 2018-01-01 to 2018-12-31 | −$765.5k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2018-12-31 | $369 | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-12-31 | $42.3k | us-gaap:AssetsCurrent |
| Total assets | at 2018-12-31 | $2.6m | us-gaap:Assets |
| Current liabilities | at 2018-12-31 | $1.4m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2018-12-31 | $1.2m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1479681/000160706219000163/igmb123118form10ka.htm

Filed Apr 17, 2019.
Source: SEC EDGAR, the filing index for accession 0001607062-19-000163. Last ingested by Listed: Nov 14, 2026, 12:46 ET. No prices; not investment advice.
